do glp-1 cause muscle loss Weight with medicines does not result in a disproportionate loss of mass or function in obese mice and humans Glucagon-Like Peptide-1: New Regulator in

Combination Therapies: Novel combination products of insulin and GLP-1 receptor agonists are developed and introduced

As always, this content is for educational purposes only and should not be used as medical advice

Please do not ask questions that use sensitive or confidential information

The published case report describing severe psychiatric symptoms, including paranoia and hallucinations, involved compounded tirzepatide

Four states dropped coverage in late 2025: California, New Hampshire, Pennsylvania , and South Carolina all eliminated Medicaid coverage of GLP-1s for obesity treatment reducing the national count from 16 states to 13